Danjun Wu

1.5k total citations
34 papers, 1.2k citations indexed

About

Danjun Wu is a scholar working on Pharmaceutical Science, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Danjun Wu has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmaceutical Science, 16 papers in Biomaterials and 10 papers in Biomedical Engineering. Recurrent topics in Danjun Wu's work include Advanced Drug Delivery Systems (17 papers), Nanoparticle-Based Drug Delivery (16 papers) and Nanoplatforms for cancer theranostics (8 papers). Danjun Wu is often cited by papers focused on Advanced Drug Delivery Systems (17 papers), Nanoparticle-Based Drug Delivery (16 papers) and Nanoplatforms for cancer theranostics (8 papers). Danjun Wu collaborates with scholars based in China, Russia and France. Danjun Wu's co-authors include Thierry Delair, Jingou Ji, Yi Xu, Gensheng Yang, Shilei Hao, Shumin Xu, Xueling Zhang, Yi Li, Weiqi Liu and Qinying Yan and has published in prestigious journals such as ACS Applied Materials & Interfaces, Carbohydrate Polymers and The Journal of Organic Chemistry.

In The Last Decade

Danjun Wu

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danjun Wu China 20 502 343 306 217 211 34 1.2k
Somsak Saesoo Thailand 21 568 1.1× 289 0.8× 242 0.8× 194 0.9× 201 1.0× 26 1.1k
Mohammad Reza Avadi Iran 16 532 1.1× 607 1.8× 341 1.1× 163 0.8× 167 0.8× 24 1.3k
Supriya Shidhaye India 12 495 1.0× 477 1.4× 306 1.0× 166 0.8× 232 1.1× 29 1.2k
Yongmei Xu China 9 608 1.2× 509 1.5× 227 0.7× 128 0.6× 156 0.7× 17 1.2k
Mohamad Tarhini France 11 461 0.9× 224 0.7× 245 0.8× 162 0.7× 307 1.5× 16 1.2k
Bader M. Aljaeid Saudi Arabia 17 453 0.9× 528 1.5× 352 1.2× 130 0.6× 301 1.4× 27 1.4k
Jiafu Cao South Korea 24 600 1.2× 380 1.1× 297 1.0× 257 1.2× 381 1.8× 42 1.7k
Gro Smistad Norway 25 411 0.8× 555 1.6× 500 1.6× 183 0.8× 235 1.1× 60 1.7k
Jülide Akbuğa Türkiye 25 470 0.9× 578 1.7× 515 1.7× 177 0.8× 169 0.8× 84 1.7k
José Mário Barichello Brazil 17 368 0.7× 491 1.4× 362 1.2× 181 0.8× 155 0.7× 30 1.2k

Countries citing papers authored by Danjun Wu

Since Specialization
Citations

This map shows the geographic impact of Danjun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danjun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danjun Wu more than expected).

Fields of papers citing papers by Danjun Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danjun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danjun Wu. The network helps show where Danjun Wu may publish in the future.

Co-authorship network of co-authors of Danjun Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Danjun Wu. A scholar is included among the top collaborators of Danjun Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danjun Wu. Danjun Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Danjun, Yazhen Li, Hong Tian, et al.. (2025). Stabilization of chitosan-based nanomedicines in cancer therapy: a review. International Journal of Biological Macromolecules. 309(Pt 4). 143016–143016. 3 indexed citations
2.
3.
Wu, Danjun, et al.. (2024). Chitosan nanomedicines-engineered bifidobacteria complexes for effective colorectal tumor-targeted delivery of SN-38. International Journal of Pharmaceutics. 659. 124283–124283. 7 indexed citations
4.
Wu, Danjun, et al.. (2024). Near-infrared Light-Triggered Size-Shrinkable theranostic nanomicelles for effective tumor targeting and regression. International Journal of Pharmaceutics. 658. 124203–124203. 3 indexed citations
5.
Wu, Danjun, Hong Liu, Kaili Fu, et al.. (2023). Escherichia coli Nissle 1917-driven microrobots for effective tumor targeted drug delivery and tumor regression. Acta Biomaterialia. 169. 477–488. 25 indexed citations
6.
Wu, Danjun, et al.. (2022). Gold nanorods-loaded chitosan-based nanomedicine platform enabling an effective tumor regression in vivo. International Journal of Pharmaceutics. 632. 122561–122561. 4 indexed citations
7.
Xu, Shumin, et al.. (2022). ProbioticEscherichia coliNISSLE 1917 for inflammatory bowel disease applications. Food & Function. 13(11). 5914–5924. 64 indexed citations
8.
Wu, Danjun, Yi Li, Shumin Xu, et al.. (2021). A biocompatible superparamagnetic chitosan-based nanoplatform enabling targeted SN-38 delivery for colorectal cancer therapy. Carbohydrate Polymers. 274. 118641–118641. 22 indexed citations
9.
Guo, Fangyuan, Kang Zhou, Cheng‐Hao Jin, et al.. (2020). Matrix metalloprotein-triggered, cell penetrating peptide-modified star-shaped nanoparticles for tumor targeting and cancer therapy. Journal of Nanobiotechnology. 18(1). 48–48. 67 indexed citations
10.
Yan, Qinying, Jiaqi Weng, Weiwei Wang, et al.. (2020). Characteristics, Cryoprotection Evaluation and In Vitro Release of BSA-Loaded Chitosan Nanoparticles. Marine Drugs. 18(6). 315–315. 24 indexed citations
11.
Wu, Danjun, Yi Li, Xueling Zhang, et al.. (2020). Chitosan-based Colloidal Polyelectrolyte Complexes for Drug Delivery: A Review. Carbohydrate Polymers. 238. 116126–116126. 218 indexed citations
12.
Guo, Fangyuan, Qinying Yan, Qingliang Yang, et al.. (2019). <p>Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology</p>. International Journal of Nanomedicine. Volume 14. 4683–4695. 18 indexed citations
13.
He, Yi, et al.. (2019). A gold-triggered dearomative spirocarbocyclization/Diels–Alder reaction cascade towards diverse bridged N-heterocycles. Organic & Biomolecular Chemistry. 17(43). 9529–9536. 18 indexed citations
14.
He, Yi, Zhen Liu, Danjun Wu, et al.. (2019). Modular Access to Diverse Bridged Indole Alkaloid Mimics via a Gold-Triggered Cascade Dearomative Spirocarbocyclization/[4 + 2] Cycloaddition Sequence. Organic Letters. 21(12). 4469–4474. 44 indexed citations
15.
Wu, Danjun, et al.. (2017). Ternary polysaccharide complexes: Colloidal drug delivery systems stabilized in physiological media. Carbohydrate Polymers. 172. 265–274. 5 indexed citations
16.
Wu, Danjun, Bernard Verrier, Charlotte Primard, et al.. (2016). Zinc-Stabilized Chitosan-Chondroitin Sulfate Nanocomplexes for HIV-1 Infection Inhibition Application. Molecular Pharmaceutics. 13(9). 3279–3291. 32 indexed citations
17.
Wu, Danjun & Thierry Delair. (2014). Stabilization of chitosan/hyaluronan colloidal polyelectrolyte complexes in physiological conditions. Carbohydrate Polymers. 119. 149–158. 78 indexed citations
18.
Ji, Jingou, et al.. (2012). Preparation, evaluation, and in vitro release of folic acid conjugated O‐carboxymethyl chitosan nanoparticles loaded with methotrexate. Journal of Applied Polymer Science. 125(S2). 30 indexed citations
19.
Ji, Jingou, et al.. (2011). Preparation, Characterization of Hydrophobic Drug in Combine Loaded Chitosan/Cyclodextrin/Trisodium Citrate Nanoparticles and in vitro Release Study. 高等学校化学研究(英文版). 28(1). 166–170. 3 indexed citations
20.
Ji, Jingou, et al.. (2010). Preparation, characterization of hydrophilic and hydrophobic drug in combine loaded chitosan/cyclodextrin nanoparticles and in vitro release study. Colloids and Surfaces B Biointerfaces. 83(1). 103–107. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026